Predictive factors for interferon and ribavirin combination therapy in patients with chronic hepatitis C

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 13, Issue 46

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

194

HTML

1561

Figures (1-2)

168

Tables (1-5)

139

Sum=2062

Dec 14, 2007 (publication date) through Apr 24, 2024

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Rapid Communication

World J Gastroenterol. Dec 14, 2007; 13(46): 6236-6242
Published online Dec 14, 2007. doi: 10.3748/wjg.v13.i46.6236

Table 5 Logistic regression analysis of ISDR

¹ISDR wild type had no mutation. Intermediate type had 1-3 mutations and mutant type had more than 4 mutations.

²After adjustment for age and HCV RNA titer before treatment. OR: Odds ratio; 95% CI: 95% confidence interval.

Citation: Yoon J, Lee JI, Baik SK, Lee KH, Sohn JH, Lee HW, Namkung J, Chang SJ, Choi JW, Kim HW, Yeh BI. Predictive factors for interferon and ribavirin combination therapy in patients with chronic hepatitis C. World J Gastroenterol 2007; 13(46): 6236-6242
URL: https://www.wjgnet.com/1007-9327/full/v13/i46/6236.htm
DOI: https://dx.doi.org/10.3748/wjg.v13.i46.6236